TOP STORIES

• REGULATORY MHLW to Issue Basic Guide to PMS for Conditional Early Approval: Drug Review Chief
  October 11, 2017

• REGULATORY Japan Needs “Quick and Low-Cost” R&D Setup: Top MD Bureaucrat
  October 10, 2017

• REGULATORY MHLW to Place Priority on “Mutual Understanding” with Industry: Economic Affairs Chief
  October 6, 2017

• REGULATORY Payers Oppose Price Hikes based on CEA at 1st Joint Meeting: Chuikyo
  October 5, 2017

• BUSINESS Japan Debut of MSD’s Zetia/Lipitor Combo Delayed as Cyberattack Woes Continue
  October 4, 2017

• REGULATORY MHLW Wants to Introduce Conditional Early Approval System This Month: Minister
  October 3, 2017

• REGULATORY (Update) Bayer Told to Improve Practice over ADR Reporting Delays, Gets “Verbal Guidance” for Xarelto Survey Fuss
  October 2, 2017

• REGULATORY MHLW Unveils Planned Framework for Conditional Early Approval Scheme
  September 29, 2017

• REGULATORY MHLW OKs Japan’s 1st PD-L1 Inhibitor, 8-Week Hep C Med, Ibrance and More
  September 28, 2017

• REGULATORY As Complaints of Shortages Grow for Japanese Encephalitis Vaccine, MHLW Plans Centralized Collection/Feedback of Supply-Demand Data for Distributers
  September 27, 2017

• TRENDS Japan’s “NDB” Insurance Claim Database Corroborates Slack SGLT-2 Prescriptions for Older People in FY2015
  September 26, 2017

• BUSINESS Opdivo Gains Nod for Gastric Cancer; Spinraza Now Available for All SMA Patients
  September 25, 2017

• BUSINESS Medipal to Become JCR’s Top Shareholder, Poised to Form JV in US
  September 22, 2017

• BUSINESS CSL Ramping Up Investment for New Product Development, 11% R&D-to-Sales Ratio “Appropriate”: CEO
  September 22, 2017

• REGULATORY Kaketsuken in Talks with “Several Entities” over Possible Biz Transfer: New Chief
  September 21, 2017

• BUSINESS NCC, Top 3 Japan Makers Form Immunotherapy Consortium with Eye on Alternative to PD-1 Inhibitors
  September 20, 2017

• BUSINESS Armed with Japanese Data, Nichi-Iko Confident of Besting Nippon Kayaku in Remicade Biosimilar Race
  September 19, 2017

• BUSINESS Chugai’s On-the-Spot ADR Info Provisioning Tools Well Received by Physicians, Spreading to Other Makers
  September 15, 2017

• REGULATORY With 253 Billion Yen Estimate Out, Chuikyo Members Prod MHLW to Vet Impact of Price Maintenance Premium
  September 14, 2017

• REGULATORY (Update) Similar “Treatment” Comparison Method Could Be Up for Discussion as New Pricing Scheme: Chuikyo
  September 13, 2017

ページ

• « 先頭
• ‹ Prev
• …
• 136
• 137
• 138
• 139
• 140
• 141
• 142
• 143
• 144
• …
• Next ›
• 最終 »